- Researchers use proteomics to identify six subtypes in non-small cell lung cancer associated with specific therapeutic targets and immune-evasion mechanisms and also demonstrate clinical utilization of the subtypes by mass-spectrometry based classification of late-stage lung cancer biopsies https://www.nature.com/articles/s43018-021-00259-9 2 comments science